Dziedzic’s Senate seat will be vacant at the start of the 2025 session in January, leaving the Senate tied 33-33.

The prognostic implications of therapies in this population were previously unknown, so investigators analyzed the respective ...

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it. The symptoms of ovarian cancer — nausea, bloating, diarrhea, constipation, and discomfort ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

Uncover shocking connections between endometriosis and ovarian cancer risk, with key insights on prevention and monitoring ...

Health experts lamented that the widespread abuse of fertility drugs, particularly in unmonitored settings, was putting women ...

Former Minnesota DFL Senate leader Kari Dziedzic died on Friday after a long battle with cancer. She was 62.Her family ...

Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National ...

Minnesota Sen. Kari Dziedzic has died of cancer. Her death comes less than a year after she announced her cancer had returned ...

Cardinalizumab (Ketanil) is a bi-specific antibody acts as programmed death 1 protein (PD-1) antagonist and CTLA4 antagonist. It is formulated as solution for inravenous route of administration.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...